Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Barrington Research Weighs in on Cross Country Healthcare, Inc.'s Q2 2024 Earnings (NASDAQ:CCRN)

Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) - Research analysts at Barrington Research reduced their Q2 2024 earnings estimates for shares of Cross Country Healthcare in a research note issued to investors on Monday, May 6th. Barrington Research analyst K. Steinke now expects that the business services provider will post earnings per share of $0.15 for the quarter, down from their prior forecast of $0.18. Barrington Research has a "Outperform" rating and a $21.00 price target on the stock. The consensus estimate for Cross Country Healthcare's current full-year earnings is $0.77 per share.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings results on Wednesday, May 1st. The business services provider reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.02. The firm had revenue of $379.17 million during the quarter, compared to analyst estimates of $374.38 million. Cross Country Healthcare had a return on equity of 11.69% and a net margin of 2.58%. Cross Country Healthcare's quarterly revenue was down 39.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.84 earnings per share.

Several other research analysts have also recently issued reports on the stock. Truist Financial dropped their target price on shares of Cross Country Healthcare from $22.00 to $16.00 and set a "hold" rating on the stock in a report on Thursday, February 22nd. TheStreet downgraded shares of Cross Country Healthcare from a "b-" rating to a "c+" rating in a research note on Friday, March 1st. Finally, Benchmark cut their price objective on shares of Cross Country Healthcare from $21.00 to $19.00 and set a "buy" rating on the stock in a report on Thursday, May 2nd. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, Cross Country Healthcare has an average rating of "Hold" and an average target price of $20.83.


Check Out Our Latest Analysis on CCRN

Cross Country Healthcare Trading Up 0.2 %

Shares of CCRN traded up $0.03 during midday trading on Wednesday, reaching $16.47. 182,558 shares of the stock were exchanged, compared to its average volume of 450,787. The company has a market capitalization of $572.73 million, a P/E ratio of 12.65, a PEG ratio of 2.17 and a beta of 0.77. Cross Country Healthcare has a 52 week low of $15.65 and a 52 week high of $28.75. The company's 50 day moving average is $17.86 and its two-hundred day moving average is $19.90.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. SG Americas Securities LLC acquired a new position in Cross Country Healthcare in the 3rd quarter worth approximately $453,000. Raymond James & Associates purchased a new position in shares of Cross Country Healthcare during the third quarter worth $2,097,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Cross Country Healthcare by 305.8% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,570 shares of the business services provider's stock valued at $584,000 after purchasing an additional 17,762 shares during the period. TD Asset Management Inc boosted its holdings in Cross Country Healthcare by 87.0% in the third quarter. TD Asset Management Inc now owns 14,400 shares of the business services provider's stock valued at $357,000 after purchasing an additional 6,700 shares during the last quarter. Finally, Paradiem LLC grew its position in Cross Country Healthcare by 5.0% during the 3rd quarter. Paradiem LLC now owns 131,989 shares of the business services provider's stock worth $3,272,000 after purchasing an additional 6,341 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Karen Mote sold 6,216 shares of the company's stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $16.95, for a total transaction of $105,361.20. Following the transaction, the insider now directly owns 35,101 shares of the company's stock, valued at approximately $594,961.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.90% of the company's stock.

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Search Headlines: